Dermatology NewsFDA opens abbreviated approval pathway for interchangeable biosimilarsJanuary 26, 2017PsoriasisPsoriatic Arthritis
Severe Henoch-Schönlein Purpura Complicating Infliximab Therapy for Ulcerative ColitisJanuary 25, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsBone fractures more likely to occur in psoriasis, PsA patientsJanuary 24, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsFixed combination topical shows promise for psoriasisJanuary 19, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsChildhood psoriasis negatively impacts parental QOLJanuary 19, 2017PsoriasisPsoriatic Arthritis
Debunking Psoriasis Myths: Do Systemic Steroids Used in Psoriasis Patients Cause Pustular Psoriasis?January 18, 2017Psoriasis
Dermatology NewsMedicare payments set for infliximab biosimilar InflectraJanuary 10, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsInitial suboptimal responders to secukinumab usually bloom laterDecember 21, 2016PsoriasisPsoriatic Arthritis
Dermatology NewsSecukinumab tames severe scalp psoriasisDecember 21, 2016PsoriasisPsoriatic Arthritis
Dermatology NewsIxekizumab proves highly effective for palmoplantar, scalp psoriasisDecember 21, 2016PsoriasisPsoriatic Arthritis
Dermatology NewsLatest ixekizumab safety data called ‘very reassuring’December 13, 2016PsoriasisPsoriatic Arthritis
Psoriasis and Internal Disease: Report From the Mount Sinai Winter SymposiumDecember 5, 2016Psoriasis
Psoriasis Treatment Considerations in Military Patients: Unique Patients, Unique DrugsDecember 2, 2016Psoriasis